CD58 (LFA-3), Human Antibody from MILTENYI BIOTEC B.V. & Co. KG
Search, find, compare suppliers for anti-CD58 (LFA-3), Human antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | CD58 (LFA-3), Human |
| Clone | TS2/9 |
| Host Species | Mouse |
| Reactive Species | human |
| Isotype | IgG1κ |
| Format | biotin conjugate |
| Size | 30 tests in 300 µL |
| Concentration | 1:11 |
| Applications | Flow cytometry |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | CD58 (LFA-3) Antibody, anti-human, Biotin. The monoclonal antibody TS2/9 recognizes human CD58, a 45-70 kDa cell surface molecule which is a member of the immunoglobin superfamily. It is expressed on professional antigen-presenting cells (APCs) such as B cells, dendritic cells, macrophages, and epithelial cells as well as on T cells, monocytes, erythrocytes, endothelial cells, and fibroblasts. LFA-3 interacts with CD2 on T cells and is important for interaction between T cells and professional APCs. |
| Immunogen | n/a |
| Other Names | LFA-3, ag3 |
| Gene, Accession # | n/a |
| Catalog # | 130-105-094 |
| Price | $99 |
| Order / More Info | CD58 (LFA-3), Human Antibody from MILTENYI BIOTEC B.V. & Co. KG |
| Product Specific References | Sanchez-Madrid, F. et al. (1982) Three distinct antigens associated with human T-lymphocyte-mediated cytolysis: LFA-1, LFA-2, and LFA-3. Proc. Natl. Acad. Sci. U.S.A. 79: 7489-7493. | Dengler, T. J. et al. (1992) Structural and functional epitopes of the human adhesion receptor CD58 (LFA-3). Eur. J. Immunol. 22 (11): 2809-2817. | Wang, J. H. et al. (1999) Structure of a heterophilic adhesion complex between the human CD2 and CD58 (LFA-3) counterreceptors. Cell 97 (6): 791-803. |
MILTENYI BIOTEC B.V. & Co. KG
MILTENYI BIOTEC B.V. & Co. KG
Friedrich-Ebert-StraÃe 68
51429 Bergisch Gladbach GERMANY
P: +49 2204 8306-0
F: +49 2204 85197
macs@miltenyibiotec.de
https://www.miltenyibiotec.com
Profile of MILTENYI BIOTEC B.V. & Co. KG
Return to Antibodies